LUMAKRAS Met Primary Endpoint of Progression-Free Survival, Demonstrating Superiority Over Standard of Care Docetaxel Chemotherapy, in KRAS G12C-Mutated Non-Small Cell Lung Cancer Detailed Data to be Presented at an Upcoming Medical Congress THOUSAND OAKS, Calif., Aug. 30, 2022…
Related Posts
Sandvik completes the acquisition of PCD tools manufacturer
STOCKHOLM, Sept. 2, 2022 /PRNewswire/ — Sandvik has completed the previously announced acquisition of the Portugal-based company Frezite. Frezite’s offering…
PRIMO WATER CORPORATION EXITS RUSSIA
TAMPA, Fla., July 21, 2022 /PRNewswire/ – Primo Water Corporation (NYSE: PRMW) (TSX: PRMW) (“Primo”), a leading provider of sustainable…
Asia-Pacific Smart Metering Markets 2022-2027 with Landis+Gyr, Itron, EDMI (Osaki Electric) and Trilliant Dominating
DUBLIN, Aug. 11, 2022 /PRNewswire/ — The “Smart Metering in Asia-Pacific” report has been added to ResearchAndMarkets.com’s offering. Asia-Pacific soon…